Johnson & Johnson (HAM:JNJ) Cyclically Adjusted Book per Share: €27.66 (As of Mar. 2026)


HAM:JNJ Johnson & Johnson HAM:JNJ
81 GF Score
Price €225.25
GF Value €165.83
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson Cyclically Adjusted Book per Share?

Johnson & Johnson HAM:JNJ -1.01% 81 Cyclically Adjusted Book per Share is €27.66 as of Mar. 2026. GuruFocus rates HAM:JNJ with a GF Score™ of 81/100 and a GF Value™ of €165.83 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Johnson & Johnson's adjusted book value per share for the three months ended in Mar. 2026 was €29.181. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €27.66 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Johnson & Johnson's average Cyclically Adjusted Book Growth Rate was 2.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 1.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 3.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Johnson & Johnson was 14.50% per year. The lowest was 1.70% per year. And the median was 10.60% per year.

As of today (2026-07-07), Johnson & Johnson's current stock price is €225.25. Johnson & Johnson's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €27.66. Johnson & Johnson's Cyclically Adjusted PB Ratio of today is 8.14.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Johnson & Johnson was 8.21. The lowest was 4.60. And the median was 5.48.


Johnson & Johnson  (HAM:JNJ) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Johnson & Johnson's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=225.25/27.66
=8.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Johnson & Johnson was 8.21. The lowest was 4.60. And the median was 5.48.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Johnson & Johnson Cyclically Adjusted Book per Share Related Terms


Johnson & Johnson Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Johnson & Johnson's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson Cyclically Adjusted Book per Share Chart

Johnson & Johnson Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.92 28.22 27.54 29.79 26.86

Johnson & Johnson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.93 26.62 26.55 26.86 27.66

HAM:JNJ vs ABBV, MRK, AMGN: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Cyclically Adjusted PB Ratio falls into.


HAM:JNJ
81GF Score
Johnson & Johnson HAM:JNJ
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Johnson & Johnson Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Johnson & Johnson's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=29.181/330.2130*330.2130
=29.181

Current CPI (Mar. 2026) = 330.2130.

Johnson & Johnson Quarterly Data

Book Value per Share CPI Adj_Book
201606 23.561 241.018 32.280
201609 23.815 241.428 32.573
201612 24.665 241.432 33.735
201703 24.405 243.801 33.055
201706 23.838 244.955 32.135
201709 23.117 246.819 30.928
201712 18.951 246.524 25.384
201803 19.126 249.554 25.308
201806 20.070 251.989 26.300
201809 20.642 252.439 27.002
201812 19.728 251.233 25.930
201903 19.647 254.202 25.522
201906 20.361 256.143 26.249
201909 20.089 256.759 25.836
201912 20.332 256.974 26.127
202003 21.072 258.115 26.958
202006 21.245 257.797 27.213
202009 20.796 260.280 26.384
202012 19.759 260.474 25.049
202103 21.005 264.877 26.186
202106 21.942 271.696 26.668
202109 22.690 274.310 27.314
202112 24.919 278.802 29.514
202203 25.799 287.504 29.631
202206 27.475 296.311 30.619
202209 28.792 296.808 32.032
202212 27.741 296.797 30.864
202303 25.475 301.836 27.870
202306 26.697 305.109 28.894
202309 27.726 307.789 29.746
202312 26.200 306.746 28.204
202403 26.766 312.332 28.298
202406 27.612 314.175 29.022
202409 26.259 315.301 27.501
202412 28.365 315.605 29.678
202503 30.034 319.799 31.012
202506 28.269 322.561 28.940
202509 28.071 324.800 28.539
202512 28.920 324.054 29.470
202603 29.181 330.213 29.181

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €27.66 mean?
Johnson & Johnson (HAM:JNJ) has a Cyclically Adjusted Book per Share of €27.66 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Johnson & Johnson and its competitors.
Is Johnson & Johnson's Cyclically Adjusted Book per Share too high?
Johnson & Johnson's current Cyclically Adjusted Book per Share is €27.66. Overall, Johnson & Johnson has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Johnson & Johnson's Cyclically Adjusted Book per Share compare to ABBV and MRK?
Johnson & Johnson's Cyclically Adjusted Book per Share of €27.66 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Johnson & Johnson and its competitors. Johnson & Johnson's current Cyclically Adjusted Book per Share is €27.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson & Johnson stock overvalued right now?
Based on GuruFocus' analysis, Johnson & Johnson (HAM:JNJ) is currently considered Significantly Overvalued. The stock's GF Value™ is €165.83, compared to a current price of €225.25 — trading 35.8% above its estimated fair value. The current Cyclically Adjusted Book per Share is €27.66. Johnson & Johnson's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Johnson & Johnson (HAM:JNJ), the current Cyclically Adjusted Book per Share is €27.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Johnson & Johnson (HAM:JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of €225.25 is trading 35.8% above its estimated GF Value™ of €165.83. GuruFocus considers Johnson & Johnson to be Significantly Overvalued.

Key valuation signals for HAM:JNJ:

  • Cyclically Adjusted Book per Share: €27.66
  • GF Value™: €165.83 vs. price of €225.25 (35.8% above fair value)
  • GF Score™: 81/100 with 7 warning signs

No single metric tells the full story. See the HAM:JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
81GF Score

Get the complete analysis for HAM:JNJ

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€225.25
Price
€165.83
GF Value